Cabazitaxel 99% CAS 183133-96-2 maka nkedo-eguzogide ọrịa prostate

Nkọwa dị mkpirikpi:

Cabazitaxel bụ API mgbochi tumor.Nnwale ụlọ ọgwụ egosila na ọ nwekwara ike ibelata etuto ahụ, belata uto ma ọ bụ mgbasa nke etuto ahụ, belata ihe mgbaàmà nke ọrịa kansa prostate ma melite ogo ndụ ndị ọrịa.Cabazitaxel na ngwakọta na prednisone maka ọgwụgwọ nke hormone-refractory metastatic prostate cancer na mbụ ejiri usoro nwere docetaxel.Hand Bio na-enye cabazitaxel 99% CAS 183133-96-2 maka ọrịa kansa prostate na-eguzogide nkedo.Maka nkọwa ndị ọzọ, biko nweere onwe gị ịkpọtụrụ n'ịntanetị.


Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:Cabazitaxel

Nọmba CAS:183133-96-2

Usoro kemịkalụ:C45H57NO14

Nkọwapụta:99%

Agba:ọcha ma ọ bụ na-acha ọcha ntụ ntụ

Isi mmalite:Semi-synthesized na 10-DAB

Ụdị:API

Ọrụ

Nnwale ụlọ ọgwụ egosila na cabazitaxel nwere ike ibelata etuto ahụ, belata uto ma ọ bụ mgbasa nke etuto ahụ, ma belata ihe mgbaàmà nke ọrịa kansa prostate.

Mpaghara ngwa

Ụlọ ọrụ ọgwụ

Ike nke Hande

Hande nwere otu R&D ruo ọtụtụ afọ.Ndị otu ahụ etinyela akwụkwọ maka ọtụtụ ihe achọpụtara ikike, na usoro ahụ enweghị nkebi site na ụlọ nyocha ruo na mmepụta nnukwu azụmahịa.Isi ihe nrụpụta GMP wuru onwe ya agafeela nyocha usoro iwu nke US FDA, EU EDQM, China GMP, Japan PMDA, Australia TGA, South Korea, India, China Taiwan, Turkey, Russia, SGS, Dun & Bradstreet na ụkpụrụ ndị ọzọ.N'otu oge ahụ, ụlọ ọrụ ahụ na-eji otu nyocha na mmepe mmepe, wee nweta ọtụtụ akwụkwọ ikike.QC ule ụlọ, ukwuu ghọta ngwaahịa ihe ule.

Ụlọ ọrụ Hande

Bụrụ onye na-ebubata akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!

Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com


  • Nke gara aga:
  • Osote: